Csenge Advisory Group Astrazeneca PLC Transaction History

Csenge Advisory Group

$1.97 Billion
Q3 2024

A detailed history of Csenge Advisory Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Csenge Advisory Group holds 3,559 shares of AZN stock, worth $229,341. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,559

Previous 2,994 18.87%

Holding current value

$229,341

Previous $233,000 18.88%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $43,318 - $49,505	565 Added 18.87%	3,559 $277,000
Q2 2024 Jul 10, 2024	BUY	$66.81 - $80.83 $200,029 - $242,005	2,994 New	2,994 $233,000
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $650 - $845	-12 Reduced 0.25%	4,720 $320,000
Q3 2022 Oct 04, 2022	SELL	$53.02 - $135.75 $55,299 - $141,587	-1,043 Reduced 18.06%	4,732 $260,000
Q2 2022 Jul 27, 2022	SELL	$59.26 - $71.14 $205,395 - $246,571	-3,466 Reduced 37.51%	5,775 $382,000
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $22,120 - $26,646	-397 Reduced 4.12%	9,241 $613,000
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $199,333 - $235,532	-3,690 Reduced 27.69%	9,638 $581,000
Q3 2021 Oct 20, 2021	BUY	$55.56 - $60.79 $205,016 - $224,315	3,690 Added 38.29%	13,328 $795,000
Q2 2021 Jul 21, 2021	BUY	$48.42 - $60.18 $242,487 - $301,381	5,008 Added 108.16%	9,638 $581,000
Q1 2021 Apr 28, 2021	SELL	$47.16 - $54.44 $8,866 - $10,234	-188 Reduced 3.9%	4,630 $231,000
Q4 2020 Jan 26, 2021	BUY	$48.52 - $58.02 $233,769 - $279,540	4,818 New	4,818 $241,000
Q4 2018 Feb 07, 2019	SELL	$36.86 - $41.49 $13,859 - $15,600	-376 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$34.76 - $39.72 $13,069 - $14,934	376 New	376 $15,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account

Csenge Advisory Group Astrazeneca PLC Transaction History